Direct oral anticoagulants: Still too early for prime time after pulmonary endarteriectomy?
J Thromb Haemost
.
2020 Mar;18(3):758-759.
doi: 10.1111/jth.14706.
Authors
Laurent Bertoletti
1
2
3
,
Xavier Jaïs
4
,
Souad Bezzeghoud
1
3
,
Xavier Delavenne
2
5
Affiliations
1
Department of Vascular Medicine and Therapeutics, University Hospital of Saint-Etienne, Saint-Etienne, France.
2
Inserm UMR1059, Sainbiose DVH, University of Saint-Etienne, Saint-Etienne, France.
3
Inserm CIC-EC 1408, Saint-Etienne, France.
4
AP-HP, Service de Pneumologie, Centre de Référence de l'Hypertension Pulmonaire, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
5
Laboratory of Pharmacology and Toxicology, University Hospital of Saint-Etienne, Saint-Etienne, France.
PMID:
32112534
DOI:
10.1111/jth.14706
No abstract available
Publication types
Letter
Comment
MeSH terms
Anticoagulants*
Humans
Hypertension, Pulmonary*
Vitamin K
Substances
Anticoagulants
Vitamin K